NGS-Based RNA-Sequencing Market Growth Accelerates: Strategic Forecast Predicts $10.26 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the NGS-Based RNA-Sequencing Industry Market Size Be by 2025?
The market size for ngs-based rna-sequencing has witnessed a dramatic increase in the past few years. It is projected to escalate from $3.41 billion in 2024 to $4.2 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 23.3%. The significant growth during the historic period can be ascribed to initiatives in genomic research, diminishing costs of sequencing, advancements in drug discovery and development, personalized medicine, and an uptick in the adoption of ngs.

What's the Long-Term Growth Forecast for the NGS-Based RNA-Sequencing Market Size Through 2029?
In the coming years, the market size for ngs-based rna-sequencing is predicted to undergo exponential expansion. The market value is anticipated to rise to $10.26 billion by 2029, with a compound annual growth rate (CAGR) of 25.0%. This expected growth during the forecast period can be linked to factors such as clinical diagnostics, global collaborations, agricultural and environmental research, green genomics, and ethical and regulatory frameworks. Notable trends for the forecast period encompass single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, sustainable agriculture, and multi-omics integration.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

What Are the Key Growth Drivers Fueling the NGS-Based RNA-Sequencing Market Expansion?
The rise in precision medicine is fueling the NGS-based RNA sequencing market. Precision medicine allows physicians to devise individualized treatment regimens and make therapeutic decisions based upon the genetic knowledge of a patient's illness. The prevalence of precision medicines for tackling critical diseases like cancer has been observed. The NGS-based RNA sequencing plays a pivotal role in determining the core reason for the disease and recommending the appropriate precision medicine for its cure. For instance, in February 2023, a report by the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, stated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have kept a steady proportion of at least a quarter of new drug approvals over the previous eight years, a notable surge from less than 10% a decade earlier. As the need for precision medicines escalates, so will the demand for NGS-based RNA sequencing.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

What Long-Term Trends Will Define the Future of the NGS-Based RNA-Sequencing Market?
Forming Strategic Alliances is a significant trend in the NGS-based RNA sequencing industry. Companies are establishing collaborations with NGS-based RNA sequencing firms to penetrate new markets and make the most of each other's capabilities. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, aligned with several industry and academia partners. The purpose of this collaboration is to enhance the ability to rapidly tackle public health crises and to construct a new diagnostic tool that can detect all known and emerging respiratory RNA viruses in one test.

How Is the NGS-Based RNA-Sequencing Market Segmented?
The ngs-based rna-sequencing market covered in this report is segmented -

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

Which Companies Are Leading the Charge in NGS-Based RNA-Sequencing Market Innovation?
Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, dic*kinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Which Regions Are Leading the Global NGS-Based RNA-Sequencing Market in Revenue?
North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.